This site uses cookies to improve your browsing experience. By using this site, you agree to their use. Cookie Information
Login or create an account to see restricted content
Login or Register- AT2D Slide library
- Cardiovascular Outcomes Trials
- Harmony Outcomes
Harmony Outcomes
The Harmony Outcomes CVOT assessed the cardiovascular safety of albiglutide in patients with type 2 diabetes and vascular disease. This module details the study outcomes.
Harmony Outcomes
Harmony Outcomes
Rate this content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
- Harmony Outcomes
- Harmony Outcomes
- Login or create an account to see restricted contentHarmony Outcomes
- Login or create an account to see restricted contentHarmony Outcomes: study design
- Login or create an account to see restricted contentHarmony Outcomes: primary and secondary outcomes
- Login or create an account to see restricted contentHarmony Outcomes: baseline characteristics (1/2)
- Login or create an account to see restricted contentHarmony Outcomes: baseline characteristics (2/2)
- Login or create an account to see restricted contentHarmony Outcomes: medical history at baseline
- Login or create an account to see restricted contentHarmony Outcomes: CV medication at baseline
- Login or create an account to see restricted contentHarmony Outcomes: glucose-lowering medication at baseline
- Login or create an account to see restricted contentHarmony Outcomes
- Login or create an account to see restricted contentHarmony Outcomes: primary outcome 3P-MACE (time to first occurrence of CV death, MI or stroke)
- Login or create an account to see restricted contentHarmony Outcomes: components of 3P-MACE
- Login or create an account to see restricted contentHarmony Outcomes: CV death
- Login or create an account to see restricted contentHarmony Outcomes: MI
- Login or create an account to see restricted contentHarmony Outcomes: stroke
- Login or create an account to see restricted contentHarmony Outcomes: CV outcomes
- Login or create an account to see restricted contentHarmony Outcomes: 3P-MACE across types of CV disease at baseline
- Login or create an account to see restricted contentHarmony Outcomes: 3P-MACE by HF status at baseline
- Login or create an account to see restricted contentHarmony Outcomes: 3P-MACE by baseline glucose-lowering medication
- Login or create an account to see restricted contentHarmony Outcomes: 3P-MACE by baseline HbA1c
- Login or create an account to see restricted contentHarmony Outcomes: prespecified microvascular event composite
- Login or create an account to see restricted contentHarmony Outcomes
- Login or create an account to see restricted contentHarmony Outcomes: change in HbA1c and body weight
- Login or create an account to see restricted contentHarmony Outcomes: change in systolic blood pressure
- Login or create an account to see restricted contentHarmony Outcomes: change in eGFR
- Login or create an account to see restricted contentHarmony Outcomes: time to initiation of insulin
- Login or create an account to see restricted contentHarmony Outcomes: metabolic composite outcome
- Login or create an account to see restricted contentHarmony Outcomes
- Login or create an account to see restricted contentHarmony Outcomes: AEs of special interest (1/2)
- Login or create an account to see restricted contentHarmony Outcomes: AEs of special interest (2/2)
- Login or create an account to see restricted contentHarmony Outcomes: hypoglycaemia
- Login or create an account to see restricted contentHarmony Outcomes
- Login or create an account to see restricted contentHarmony Outcomes: summary
- Login or create an account to see restricted contentBack-up slides
- Login or create an account to see restricted contentHarmony Outcomes: time to initiation of prandial insulin